Summary by Futu AI
The United States Securities and Exchange Commission (SEC) has declared that the Form S-3 filed by 60 Degrees Pharmaceuticals, Inc. is now effective as of July 18, 2024, at 9:00 A.M. The Form S-3 is a registration statement that allows companies to issue various securities to the public. The effectiveness of this form indicates that 60 Degrees Pharmaceuticals has met all the necessary regulatory requirements to potentially offer securities to investors. The company's CIK number is 0001946563, and the file number for this particular form is 333-280796.